Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-69.66	33.92	-111.82
Graham Fair Price	132.86	3.69	1.59
PEG	0.00	0.00	0.00
Price/Book	-19.00	0.32	0.39
Price/Cash Flow	-47.76	57.92	-110.87
Prices/Earnings	-85.22	14.36	97.11
Price/Sales	-84.06	16.72	104.92
Price/FCF	-47.76	57.92	-110.87
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	150.19	0.38	0.15
Operating Margin	-67.98	0.15	-0.48
ROA	454.40	< 0.005	< 0.005
ROE	< 0.005	< 0.005	447.91
ROIC	< 0.005	< 0.005	55.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	21776.50	5897.85	-72.92
Days Sales Outstanding (DSO)	0.00	79.80	100.00
Inventory Turnover	< 0.005	0.02	269.23
Debt/Capitalization	0.02	< 0.005	-80.83
Quick Ratio	5.86	8.30	41.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	10.54	10.49	-0.52
Cash	2.30	2.08	-9.59
Capex	< 0.005	< 0.005	-500.04
Free Cash Flow	-0.04	0.06	54.26
Revenue	0.04	0.20	405.60
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	26.42	38.01	43.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	111.38	-51.50	-53.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating